Zobrazeno 1 - 10 of 673 pro vyhledávání: '"Em, Ohman"'
5
Akademický článek
Intraindividual Variability in Serial Lipoprotein(a) Concentrations Among Placebo-Treated Patients in the OCEAN(a)-DOSE Trial.
Autor: Gaba P; Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA., Rosenson RS; Division of Cardiovascular Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA., López JAG; Global Development, Amgen Inc, Thousand Oaks, California, USA., Watts GF; Department of Cardiology, Royal Perth Hospital, Perth, Western Australia, Australia., Leucker TM; Department of Cardiology, Johns Hopkins, Baltimore, Maryland, USA., Kuder JF; Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA., Im K; Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA., Kassahun H; Global Development, Amgen Inc, Thousand Oaks, California, USA., Wang H; Global Development, Amgen Inc, Thousand Oaks, California, USA., Wu Y; Global Development, Amgen Inc, Thousand Oaks, California, USA., Wang J; Global Development, Amgen Inc, Thousand Oaks, California, USA., Ohman EM; Global Development, Amgen Inc, Thousand Oaks, California, USA., Sabatine MS; Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA., O'Donoghue ML; Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA. Electronic address: modonoghue@bwh.harvard.edu.
Publikováno v: Journal of the American College of Cardiology [J Am Coll Cardiol] 2024 Dec 04. Date of Electronic Publication: 2024 Dec 04.
Zobrazit plný text záznamu
6
Akademický článek
Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischemic events after percutaneous coronary intervention: A sub-study of the TWILIGHT trial.
Autor: Baber U; Department of Cardiology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Cao D; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, NY, NY, USA.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, MI, Italy., Collier T; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK., Sartori S; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, NY, NY, USA., Dangas G; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, NY, NY, USA., Angiolillo DJ; Division of Cardiology, University of Florida College of Medicine, Jacksonville, FL, USA., Vogel B; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, NY, NY, USA., Kunadian V; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University and Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Briguori C; Mediterranea Cardiocentro, Naples, Italy., Cohen DJ; Cardiovascular Research Foundation, NY, NY, USA.; St. Francis Hospital, Roslyn, Roslyn, NY, USA., Dudek D; Jagiellonian University Medical College, Krakow, Poland., Gibson CM; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Gil R; Center of Postgraduate Medical Education, Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland., Huber K; 3rd Dept Medicine, Cardiology and Intensive Care Medicine, Wilhelminen hospital, and Sigmund Freud University, Medical Faculty, Vienna, Austria., Kaul U; Batra Hospital and Medical Research Centre, New Delhi, India., Kornowski R; Rabin Medical Center, Petach Tikva, Israel., Krucoff MW; Duke University Medical Center-Duke Clinical Research Institute, Durham, NC, USA., Mehta S; Hamilton Health Sciences, Hamilton, ON, Canada., Moliterno DJ; University of Kentucky, Lexington, KY, USA., Ohman EM; Duke University Medical Center-Duke Clinical Research Institute, Durham, NC, USA., Escaned J; Hospital Clínico San Carlos IDISCC, Complutense University of Madrid, Madrid, Spain., Sardella G; Policlinico Umberto I University, Roma, Italy., Sharma SK; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, NY, NY, USA., Shlofmitz R; St. Francis Hospital, Roslyn, Roslyn, NY, USA., Weisz G; NewYork Presbyterian Hospital, Columbia University Medical Center, NY, USA., Witzenbichler B; Helios Amper-Klinikum, Dachau, Germany., Steg PG; Université de Paris and Assistance paris-Hôpitaux de Paris, Paris, France., Pocock S; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK., Mehran R; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, NY, NY, USA.
Publikováno v: European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.
Zobrazit plný text záznamu
7
Akademický článek
The Use of Cangrelor in Cardiogenic Shock: Insights from the CAMEO Registry.
Autor: Rymer J; Duke University, Durham, NC; Duke Clinical Research Institute, Durham, NC. Electronic address: jennifer.rymer@duke.edu., Pichan C; Duke University, Durham, NC., Page C; Duke Clinical Research Institute, Durham, NC., Alhanti B; Duke Clinical Research Institute, Durham, NC., Bhatt DL; Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY., Kochar A; Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY., Angiolillo DJ; University of Florida, Jacksonville, FL., Diaz M; Palmetto General Hospital, Hialeah, FL., Wimmer NJ; ChristianaCare, Newark, DE., Waksman R; Washington MedStar, Washington, D.C., Ang L; University of California San Diego, San Diego, CA., Bach R; Washington University in St. Louis, St. Louis, MO., Jenkins R; Kootenai Health, Coeur d'Alene, ID., El-Sabae H; Chiesi, Cary, NC., Brothers L; Duke Clinical Research Institute, Durham, NC., Ohman EM; Duke Clinical Research Institute, Durham, NC., Jones WS; Duke University, Durham, NC; Duke Clinical Research Institute, Durham, NC., Washam JB; Duke Clinical Research Institute, Durham, NC., Wang TY; Duke Clinical Research Institute, Durham, NC., Narcisse D; Duke University, Durham, NC., Basir MB; Henry Ford Health, Detroit, MI.
Publikováno v: Journal of cardiac failure [J Card Fail] 2024 Oct; Vol. 30 (10), pp. 1233-1240.
Zobrazit plný text záznamu
8
Akademický článek
Predictors of outcomes after PCI with incomplete revascularization: Impact of CTO and LAD vessel.
Autor: Kuno T; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Medicine, Mount Sinai Beth Israel Hospital, New York, New York, USA.; Division of Cardiology, Montefiore Medical Center, Bronx, New York, USA., Weisz G; Division of Cardiology, Columbia University Medical Center, NewYork Presbyterian Hospital, New York, New York, USA., Généreux P; Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey, USA., Claessen BE; Department of Cardiology, Heart Center, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Shechter M; The Leviev Cardiothoracic & Vascular Center, Sheba Medical Center, Tel Hashomer, Israel., Alexander KP; Duke Clinical Research Institute, Durham, North Carolina, USA., James SK; Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden., Ohman EM; Duke Clinical Research Institute, Durham, North Carolina, USA., Dressler O; Cardiovascular Research Foundation, New York, New York, USA., Mehran R; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Ben-Yehuda O; Sulpizio Cardiovascular Institute, University of California San Diego, San Diego, California, USA., Stone GW; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Publikováno v: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2024 Sep; Vol. 104 (3), pp. 483-491. Date of Electronic Publication: 2024 Jul 15.
Zobrazit plný text záznamu
9
Akademický článek
Angiogenic Gene Therapy for Refractory Angina: Results of the EXACT Phase 2 Trial.
Autor: Nakamura K; Division of Cardiology, Department of Medicine (K.N.), University of Washington, Seattle., Henry TD; The Carl and Edith Lindner Center of Research and Education, The Christ Hospital, Cincinnati, OH (T.D.H.)., Traverse JH; Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, MN (J.H.T., B.C.S.)., Latter DA; Department of Cardiovascular Surgery, St. Michael's Hospital, University of Toronto, ON, Canada (D.A.L.)., Mokadam NA; Department of Cardiac Surgery, Ohio State University Wexner Medical Center, Columbus (N.A.M.)., Answini GA; The Christ Hospital, Cincinnati, OH (G.A.A.)., Williams AR; Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC (A.R.W.)., Sun BC; Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, MN (J.H.T., B.C.S.)., Burke CR; Division of Cardiothoracic Surgery, Department of Surgery (C.R.B.), University of Washington, Seattle., Bakaeen FG; Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Foundation, OH (F.G.B.)., DiCarli MF; Departments of Radiology and Medicine, Brigham and Women's Hospital, Boston, MA (M.F.D.)., Chaitman BR; Core ECG/MI Classification Laboratory, St. Louis University School of Medicine, MO (B.R.C.)., Peterson MW; XyloCor Therapeutics, Malvern, PA (M.W.P., D.G.B., H.C.D.)., Byrnes DG; XyloCor Therapeutics, Malvern, PA (M.W.P., D.G.B., H.C.D.)., Ohman EM; Duke Clinical Research Institute and Duke Medicine, Durham, NC (E.M.O., T.J.P.)., Pepine CJ; Department of Cardiovascular Medicine, University of Florida, Gainesville (C.J.P.)., Crystal RG; Department of Genetic Medicine, Weill Cornell Medical College, New York, NY (R.G.C.)., Rosengart TK; Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX (T.K.R.)., Kowalewski E; Department of Biostatistics, University of North Carolina, Chapel Hill (E.K., G.G.K.)., Koch GG; Department of Biostatistics, University of North Carolina, Chapel Hill (E.K., G.G.K.)., Dittrich HC; XyloCor Therapeutics, Malvern, PA (M.W.P., D.G.B., H.C.D.)., Povsic TJ; Duke Clinical Research Institute and Duke Medicine, Durham, NC (E.M.O., T.J.P.).
Publikováno v: Circulation. Cardiovascular interventions [Circ Cardiovasc Interv] 2024 May; Vol. 17 (5), pp. e014054. Date of Electronic Publication: 2024 May 02.
Zobrazit plný text záznamu
10
Akademický článek
Hypertension, microvascular obstruction and infarct size in patients with STEMI undergoing PCI: Pooled analysis from 7 cardiac magnetic resonance imaging studies.
Autor: Mehdipoor G; Clinical Trials Center, Cardiovascular Research Foundation, New York, NY; Montefiore Medical Center, The University Hospital for Albert Einstein College of Medicine, Bronx, NY., Redfors B; Clinical Trials Center, Cardiovascular Research Foundation, New York, NY; Department of Molecular and Clinical Medicine, Sahlgrenska Academy, Gothenburg University, Sweden; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden., Chen S; Clinical Trials Center, Cardiovascular Research Foundation, New York, NY., Gkargkoulas F; Clinical Trials Center, Cardiovascular Research Foundation, New York, NY., Zhang Z; Clinical Trials Center, Cardiovascular Research Foundation, New York, NY., Patel MR; Duke University Heart Center, Durham, NC., Granger CB; Duke University Heart Center, Durham, NC., Ohman EM; Duke University Heart Center, Durham, NC., Maehara A; Clinical Trials Center, Cardiovascular Research Foundation, New York, NY; NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, NY., Eitel I; University Heart Center Lübeck and The German Center for Cardiovascular Research, Lübeck, Germany., Ben-Yehuda O; Clinical Trials Center, Cardiovascular Research Foundation, New York, NY; NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, NY., de Waha-Thiele S; University Heart Center Lübeck and The German Center for Cardiovascular Research, Lübeck, Germany., Thiele H; Heart Center Leipzig at University of Leipzig and Leipzig Heart Institute, Leipzig, Germany., Stone GW; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: gregg.stone@mountsinai.org.
Publikováno v: American heart journal [Am Heart J] 2024 May; Vol. 271, pp. 148-155. Date of Electronic Publication: 2024 Mar 01.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje